BTA
Click for more information
0.00% 57.0¢ biota holdings limited

According analysts’ predictions, GSK will register £1bn in sales...

  1. mk1997
    120 Posts.
    clock Created with Sketch.
    27/10/09
    07:52
    Post #: 5834345
    According analysts’ predictions, GSK will register £1bn in sales for Pandermix in the fourth quarter and £180m from Relenza in the third and fourth quarters.

    GSK will announced results on Wednesday, followed by AstraZeneca on Thursday.

    --------------
    http://www.nebusiness.co.uk/business-news/latest-business-news/gazette-business-news/2009/10/26/healthy-boost-from-swine-flu-vaccine-51140-25016605/

    BTA Price at posting: $3.12 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.